The effectiveness and safety of angiotensin-converting enzyme inhibition or receptor blockade in vascular diseases in patients with hemodialysis

Patients with end-stage renal disease (ESRD) who are on hemodialysis have high risk of vascular diseases. Our study sought to examine whether angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin type 1 receptor blockers (ARBs) could reduce the frequencies of cardiovascular and cerebrovasc...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Kuang-Ming, Cheng, Hui-Teng, Lee, Yi-Hsuan, Chen, Chung-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380296/
https://www.ncbi.nlm.nih.gov/pubmed/28353612
http://dx.doi.org/10.1097/MD.0000000000006525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380296/
https://www.ncbi.nlm.nih.gov/pubmed/28353612
http://dx.doi.org/10.1097/MD.0000000000006525

Ejemplares similares